# OnCo record nct06783140 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06783140/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06783140", "NCT06783140" ;
  schema:name "Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer"@en ;
  schema:alternateName "PLATINUM-CAN"@en ;
  schema:description "A phase 2/3 trial of nab-paclitaxel, gemcitabine and cisplatin in pancreatic cancer, run by University Health Network, Toronto, active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06783140/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06783140> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/metastatic-pdac/>, <https://onco.cc/cancers/brca-palb2-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/cisplatin/> .